tive expression 12,57 in HT vs. 19.40 in control group (CG), p = 0.0002; 12,10 in GD vs. 19.40 in CG, p = 0.0002) and in CD8 + -T-cells (13.13 in HT vs. 18,12 in CG, p = 0.02; 11.66 in GD vs. 18.12 in CG, p = 0.0002). GD and HT showed signifi cantly decreased miRNA 155_2 and miRNA 155*_1 in HT in CD8 + -T-cells (10.69 in HT vs. 11.30 in CG, p = 0.01; 10.40 in GD vs. 11.30 in CG, p = 0.005). This study confi rms signifi cant variations of miRNA200a and miRNA155 in patients suffering from GD and HT in vivo in CD4 + T-cells and CD8 + T-cells. These data may help to better understand the gene regulations in the causative cells causing these autoimmune processes. They extend our very limited knowledge concerning miRNAs in thyroid diseases.
Introduction

▼
Autoimmune thyroid diseases
Graves' disease (GD) and Hashimoto's thyroiditis (HT) are the most common autoimmune thyroid diseases (AITD). Both AITDs are similar in terms of lymphocytic infi ltrations of the thyroid gland. However, underlying cellular and humoral immune responses are clearly diff erent in the 2 entities. HT is characterized by infi ltration of autoreactive T and B cells into the thyroid gland, causing thyroid cell death [ 1 ] and production of anti-thyroperoxidase (TPO) and anti-thyroglobulin (Tg) antibodies [ 2 ] . We could previously show that cytotoxic CD8 + T-cells of HT patients recognize TPO-and Tg-antigens [ 3 ] and in cooperation with natural killer cells are involved in the disease process of HT [ 4 ] . Regulatory CD4 + T-cells are believed to play an important role in the moderation of this autoimmunological process in Hashimoto's thyroiditis [ 5 , 6 ] . The etiology of GD is dependent on the fact that thyroid auto-reactive T-cells escape immune tolerance, infi ltrate the thyroid gland and induce activation of auto-reactive B-cells that secrete thyrotropin receptor (TSH-R)-stimulating antibodies (TRAb) which cause hyperthyroidism [ 7 ] . In GD, both Th1 mediating cell mediated immunity and Th2 mediating humoral immunity occur [ 8 ] . Cytokine expression profi les in sera and thyroid tissues from Gravesʼ disease patients indicate a mixed Th1/Th2 status at any time [ 9 ] . Through both immune responses complex interactions of cytokines and chemokines mediated also through CD4 + T-cells are enabled, which beside inducing activation of auto-reactive B-cells, also lead to an activation of CD8 + T-cells contributing to the toxic reaction in the thyroid tissue [ 10 ] . The current etiopathological dogma is that AITDs are complex diseases where on the basis of susceptibility genes, environmental triggers initiate the autoimmune response to the thyroid. microRNAs microRNAs (miRNAs) constitute a family of small RNAs, 21-25-nucleotides in length, which control This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.
Hashimoto thyroiditis (HT) and Graves's disease (GD). The chosen miRNAs were selected after a careful review of the literature including GWA analysis. For TPO antibodies measurement we utilized a commercial assay using a 2-step chemiluminescence sandwich assay using directly coated magnetic microparticles (DiaSorin Kitinsert Liaison ® Anti-TPO) with a sensitivity of 51.5 % and a specifi city of 95 % determining HT. Based on the low sensitivity we defi ned HT by an at least 3 fold increase of TPO antibodies over the maximum normal range in serum and additionally a typical diff use hypoechogenic pattern on ultrasound. TRAb measurement was performed by a commercial, porcine radioreceptorassay (RRA) (DiaSorin Kitinsert Liaison ® TRAbs) with a sensitivity of 98.3 % and a specifi city of 99.2 % determing GD. Although sensitivity and specifi city were high we decided in concordance with the criteria for HT to defi ne GD by an at least 3 fold increase of TSH-receptor antibodies and additionally a hypoechogenic hypervasculated thyroid parenchyma on ultrasound. The control group consisted of age-matched individuals without autoimmune diseases. In all groups patients with a history of any neoplasm including thyroid carcinoma or currently treated for any neoplasia were excluded. Furthermore, in all participants, acute or chronic infections were excluded by clinical examination, measurement of C-reactive protein and total blood count. Baseline data included blood levels of thyroid antibodies, hormone levels of fT3, fT4 and TSH. No study participant was aff ected by another autoimmune process. At the time of taking blood samples, all GD patients were under thyreostatic therapy with methimazole or carbimazole. The treatment duration with methimazole or carbimazole lasted from 1 week to 6 months. 13 out of 19 patients were hyperthyroid, 6 were euthyroid. 18 of 21 HT patients were treated with L-Thyroxine in varying dosages (50 μg-100 μg once daily). The treatment duration with L-Thyroxine in HT patients lasted from at least 6 months up to 12 years. All of the HT patients were euthyroid. All 19 patients in the control group were euthyroid. Blood samples were drawn from an antecubital vein with subjects in supine position to PAXgene blood tubes (PreAnalytix) and to heparinized BD Vacutainer Cell Preparation Tubes (BD Biosciences). PAXgene blood tubes were incubated at room temperature for at minimum 4 h before freezing for further purpose by − 80 °C. Peripheral blood mononuclear cells (PBMC) were isolated by centrifuging (3100 RPM) heparinized whole blood samples in BD Vacutainer Cell Preparation Tubes and PBMC were frozen immediately after centrifugation for further purpose by − 80 °C.
Semiquantitative SYBR Green PCR
Total RNA, including miRNA, was extracted from blood samples collected in PAXgene tubes with Pax Gene Blood microRNA Kit (PreAnalytiX) according to manufacturer's instructions. CD4 and CD8-positive T-cells were isolated from PBMC won out of BD Vacutainer Cell Preparation Tubes by magnetic bead separation and resuspended in 0.7 ml Qiazol Lysis Reagent (Qiagen) using fi rst the Pan T-cell Separation Kit (Milteny Assay) and afterwards by CD4/CD8-positive T Micro Beads (Milteny Assay. Afterwards total RNA, including miRNA, was extracted from CD4 + and CD8 + cells and reversely transcribed with miRNeasy Mini Kit (Qiagen GmbH, Germany). All procedures were accomplished as described in the manufacturing protocols. The total RNA concentration was quantifi ed in all samples using NanoDrop ND-1000 Spectrophotometer (peqlab Biotechnologie GmbH, Germany) and the cell samples were stored at − 80 °C gene expression by virtue of complementary binding to targeted mRNA-sequences and consecutive disposal of double-stranded RNAs [ 11 ] . Since the identifi cation of the miRNA lin-4 as a regulator of developmental timing in the nematode Caenorhabditis elegans [ 12 ] it has become evident that these short non-coding RNAs act post-transcriptionally to regulate eukaryotic gene expression [ 13 ] . Accumulating data suggest that miRNA control is an important feature of the mammalian immune system. Genetic ablation of certain individual miRNAs machinery severely compromises immune development and regulation, implicating the infl uence of miRNAs in the pathophysiology of both immunity and autoimmunity [ 14 , 15 ] . In adaptive immune responses, dynamic alterations in miRNA expression have been noted and were attributed to changes in gene expression of T-cells, relating to lineage commitment and stepwise maturation [ 16 ] . Several studies have reported the involvement of miRNAs in immune cell development [ 17 -19 ] . These studies demonstrated that amongst others, miR-150, miR-155, miR-181a are important regulators of B and T cell development and play crucial roles for the establishment of a functional adaptive immune system [ 18 , 19 ] . The discovery of several key proteins in the biogenesis of miRNAs, Drosha/DGCR8, Dicer, and Argonautes in mammals, have allowed the simultaneous non-selective or partially selective ablation of hundreds of miRNAs while leaving protein-coding genes intact [ 20 , 21 ] . Selective deletion of Dicer [ 22 , 23 ] and other key proteins in individual immune subsets has been used to demonstrate that miRNAs are critical for B, NK, NKT, and T-cell development, function, and lineage stability of terminally diff erentiated lymphocytes [ 24 , 25 ] .
In conclusion, it has become increasingly clear from cell culture and animal studies that proper miRNA regulation is critical for the prevention of autoimmunity and normal immune functions.
role of miRNAs in AITDs
Recently levels of key immunoregulatory miRNAs in thyroid glands tissue of AITD patients and healthy controls have been determined by us [ 26 ] . We assumed that these miRNA variations are caused through infi ltrating activated lymphocytes, because -according to additionally performed microscopy of fi ne needle aspirations -these cells are dominant. To best of our knowledge currently there is no more data concerning this important issue.
The main aim of this study was to prove signifi cant variations of the key immunoregulatory miRNAs 155_2, miRNA 200a1, miRNA 146a1 and others selected after a careful review of the literature in PBMCs and in purifi ed CD4 + and CD8 + cells T-cells of AITD patients and healthy controls.
Material and Methods
▼
Ethics statement
The study protocol was approved by the local ethics committee: Ethikkommission der Medizinischen Fakultät der HeinrichHeine Universität Duesseldorf Germany (no. 3354) and the investigations conform to the principles outlined in the Declaration of Helsinki. All participants gave written informed consent before enrolment.
Study design and participants
This study aimed at investigating the levels of selected microRNAs in PBMCs and in CD4 + and CD8 + T-cells of patients with This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.
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FACS-analysis
We verifi ed in 3 control patients CD4 and CD8-positive T-cell isolation by magnetic bead separation. Therefore we primary performed a HLA typing by fl ow cytometry as described before [ 27 ] . Afterwards CD4 + and CD8 + T-cells isolation was conducted according to manufacturer's instructions. Finally the purity of this separation was evaluated by fl uorescence-activated cell sorting (FACS) analysis as described before [ 27 ] . In all controls the purifi cation reached over 90 %.
Statistics
All data were analyzed with the Statistical Package for the Social Sciences 20.0 (2011). Due to small sample sizes, diff erences between the mean relative miRNA expression of the control group and HT as well as GD patients were compared by means of the non-parametric Kruskal-Wallis-test. Results with p < 0.05 were considered statistically signifi cant. Bonferroni-corrected In a further step we analyzed the miRNA levels in the CD4 + T-cells in the peripheral blood in 10 GD patients, 10 HT patients and 10 controls by semiquantitative SYBR Green PCR. We found statistically signifi cant changes in expression levels of several miRNAs compared to controls ( • ▶ 
Discussion
▼
The exact etiology of the immune response in GD and HT to the thyroid is still unknown. The present study was undertaken to further evaluate the infl uence of defi ned miRNAs under suspicion to be involved in immune regulation in the thyroid tissue of patients suff ering from AITDs. We demonstrate that the miRNA 146a_1 is signifi cantly increased in PBMC of GD patients as compared to controls. Analysis of miRNA-146a gene expression unveiled a pattern of induc- tion in response to a variety of microbial components and proinfl ammatory cytokines [ 28 ] . In human lung alveolar epithelial cells, for example, increased miRNA-146a expression was found to negatively regulate the release of the proinfl ammatory chemokines IL-8 and RANTES [ 29 , 30 ] . Concerning autoimmune diseases, Nakasa et al. reported that miRNA-146a was highly expressed in rheumatoid arthritis (RA) synovial tissue compared to osteoarthritis and normal synovial tissue [ 31 ] . Our previous study could show for the fi rst time a signifi cant decrease of miRNA-155_2 in the thyroid tissue of HT patients [ 26 ] . We could now demonstrate that miRNA-146a is statistically signifi cantly increased in PBMCs of GD patients in accordance to Nakasa et al. fi ndings [ 31 ] . This result underlines the idea that GD is crucially caused by emigrating mononuclear cells producing TH2 cytokines. Through our data we can raise the thesis that modifi ed PBMCs with increased miRNA-146a infi ltrate the thyroid tissue of GD patients and may be critically involved in composing the local cytokine milieu in GD. In their meta-analysis Chen et al. could not fi nd an association between miR-146a G/C rs2910164 polymorphism and the development of autoimmune diseases [32] . That might imply that autoimmune diseases are caused by an increase of miRNA146a and not by a miRNA146a polymorphism. Furthermore we could show that both sequences of miRNA 155 (miRNA 155*_1 and miRNA 155_2) are signifi cantly decreased in CD8 + T-cells of HT patients vs. controls and that the sequence miRNA 155_2 is also signifi cantly decreased in CD8 + T-cells of GD patients vs. controls. Concerning miR-155, Thai et al. have shown that miRNA-155 has an important role in the mammalian immune system by specifi cally regulating T-helper cell differentiation and the germinal center reaction to produce an optimal T cell-dependent antibody response [ 33 ] . Because of his spadework, we considered miRNA-155 a suitable candidate miRNA modulating and being modulated in AITDs. Our previous study could show for the fi rst time a signifi cant decrease of miRNA-155_2 in the thyroid tissue of HT patients [ 26 ] . In the present work we could demonstrate that miRNA 155* 1 and miRNA 155_2 are signifi cantly decreased in CD8 + T-cells in the peripheral blood of HT patients. As shown previously in HT, CD8 + T-cells become activated, and infi ltrate into the thyroid [ 3 ] . We believe that the genetically modifi ed CD8 + positive T-cells infi ltrate the thyroid. We conclude that the post-transcriptional regulation caused through the decrease of miRNA 155 in cytotoxic CD8 + T-cells might contribute to the pathological identifi cation of the thyroid specifi c cellular antigens TPO and Tg through the CD8 + T cells and therefore being involved in the thyroid destruction as described previously. These ideas, of course, need further research. We also found a decrease of miRNA155_2 in cytotoxic CD8 + T-cells in GD patients in peripheral blood. Although it becomes increasingly clear that CD8 + T-cells activated by autoreactive B-cells contribute to the toxic reaction in the thyroid tissue in GD patients [ 10 ] up to now, the exact mechanism of this activation remains uncertain. It is believed that the activation is caused through a tricky interaction of chemokines and cytokines. In the context, the present results prompt an interesting, testable hypothesis: May the identifi ed chemo-and cytokines in GD infl uence the level of miRNA 155 in GD, that consecutively cause post-transcriptional regulations of CD8 + T-cells? Recent large-scale genome-wide association (GWA) studies of single nucleotide polymorphism (SNP) variations captured many thousands individual genetic profi les of H. sapiens and facilitated identifi cation of signifi cant genetic traits which are highly likely to infl uence the pathogenesis of several major human diseases. Glinsky analysed for the fi rst time gene expression patterns of miRNAs in association to AITDs [ 34 , 35 ] . He could show that several miRNAs including miRNA200 were associated with AITD in general and GD in particular. Prior to this fi nding the miRNA200 family has only been tied to the development and proliferation of various types of cancer [ 36 , 37 ] .
In the current study we found a decrease of miRNA 200a_1 and miRNA 200a2* in CD4 + and CD8 + T-cells in peripheral blood but not in PBMCs of GD and HT patients. We believe that these contradictory fi ndings in peripheral blood cells and thyroid tissue might be caused through involvement of diff erent cells. A decrease of miRNA200a in peripheral CD4 + of HT patients might cause an increase of proinfl ammatory Th1 cytokines which damage thyroid cells causing them to increase their production of miRNA200a. The decrease of miRNA200a in CD8 + T-cells might contribute to the pathological recognition of thyroid specifi c cellular antigens (i. e., TPO and Tg) ultimately resulting in thyroid destruction by CD8 + cells [ 3 ] . In GD, the decrease of miRNA200a in CD4 + T-cells in GD patients might also cause an increase of proinfl ammatory Th1 and may on this way contribute to the disease. The other miRNA candidates tested did not show signifi cant differences between diff erent AITDs, even though evidence exists for their involvement in immune regulation. In the 3 study groups, no signifi cant group diff erences with regard to patients' mean age were found. In the HT group women were overrepresented. This likely refl ects the 8 to 10-fold increased susceptibility of women to this disease [ 38 ] . So far, however, there is no data supporting an infl uence of gender to the expression of miRNAs. Further on all GD patients were under therapy with methimazole or carbimazole. It might be possible that thyrostatics may aff ect the expression of miRNA in GD patients. Further studies will be needed to compare GD patients under treatment to untreated GD patients.
Conclusion
▼ GD and HT are common human disorders whose exact aetiology is still unknown. Some miRNAs are suspected to infl uence autoimmune diseases. This study could confi rm signifi cant variations of miRNA146a1, miRNA200a1 and miRNA155 in PBMCs, CD4 + and CD8 + T-cells of patients suff ering from GD and HT in vivo. These data may help to better understand the cause of the autoimmune processes leading to AITDs as we proved signifi cant variations of miRNAs responsible for posttranscriptional gene regulations in the causative cells. More eff orts are required to understand the relevance of these miRNA variations in AITDs and to clearly identify the target genes.
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